TD Cowen Initiates Coverage On Arcus Biosciences with Buy Rating

Benzinga Newsdesk www.benzinga.com Neutral 54.7%

Neg 0% Neu 54.7% Pos 0%

TD Cowen analyst Tara Bancroft initiates coverage on Arcus Biosciences (NYSE:RCUS) with a Buy rating.

Comments

No comments yet. Be the first!